Search clinical trials for: Sodium hyaluronate 0.4%

Total 14061 results

Democritus University of Thrace
George Papanicolaou Hospital; Naval Hospital, Athens; Athinaiki General Clinic

Completed

Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery

Cataract

Greece
Second Affiliated Hospital of Xi'an Jiaotong University

Unknown

Effect of Artificial Tears on the Parameters of the Eye and Its Impact on IOL Power Calculation for Cataract Surgery (IOL)

Dry Eye | Cataract Senile

China
Laboratorios Sophia S.A de C.V.

Completed

Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease. (PRO-037)

Dry Eye

Mexico
Laboratorios Sophia S.A de C.V.

Completed

Phase IV Clinical Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (PRO-087)

Dry Eye

Mexico
Innovative Medical

Completed

Cross-Over Evaluation of Two Lubricating Eye Drops

Dry Eye

United States
Dr. Reddy's Laboratories Limited
TKL Research, Inc.; Accelovance

Completed

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

Head Lice

United States
Laboratorios Sophia S.A de C.V.

Active, not recruiting

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (PRO-165)

Dry Eye Syndromes

Mexico
Federal University of Minas Gerais

Completed

Use of Hyaluronic Acid as a Therapeutic Strategy for Bone Repair in Human

Alveolar Bone Loss
Laboratorios Sophia S.A de C.V.

Completed

Phase IV Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy (PRK) (PRO-037)

Photorefractive Keratectomy | Corneal De-epithelialization

Mexico
H. Lundbeck A/S

Completed

An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients

Parkinson Disease

United States
The Cleveland Clinic

Completed

Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study

Infraorbital Hollows

United States
DiscGenics, Inc.
CTI Clinical Trial and Consulting Services

Completed

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

Degenerative Disc Disease

United States
Indonesia University
Santen Pharmaceutical Co., Ltd.

Recruiting

Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia

Dry Eye Disease

Indonesia
The George Institute
University of Sydney; Fresenius Kabi; Australian and New Zealand Intensive Care...

Completed

Crystalloid Versus Hydroxyethyl Starch Trials (CHEST)

Intensive Care

Australia
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Ureter Injury

United States
Amorepacific Corporation

Completed

Cumulative Irritation Test of PAC-14028 in Healthy Volunteers

Healthy

Korea, Republic of
Peking University People's Hospital

Unknown

A Validation Study of Sodium Hyaluronate in Patients With Periarthritis of Shoulder

Periarthritis

China
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment

Ureter Injury

United States
Jin Yuan

Unknown

Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye

Dry Eye | Tear Film Insufficiency

China
Shenzhen Hospital of Southern Medical University

Unknown

Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops

Dry Eye | MGD-Meibomian Gland Dysfunction

China
Sichuan Haisco Pharmaceutical Group Co., Ltd
The First Hospital of Jilin University

Completed

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly Subjects

Healthy Elderly Subjects

China
Ferring Pharmaceuticals

Completed

Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Pierre Fabre Medicament

Withdrawn

Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis (VESTA)

Knee Osteoarthritis
Ramathibodi Hospital

Completed

Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes

Dry Eye

Thailand
Sunstar Americas

Completed

GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery

Periodontal Diseases | Alveolar Bone Loss

United States
Sun Yat-sen University

Unknown

0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients

Diabetes Mellitus | Dry Eye Syndromes

China
Laboratoires Thea

Completed

Efficacy of T2259 in DED

Dry Eye Syndromes

France
Allergan

Completed

Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

Dry Eye Syndromes

Germany
Laboratorios Sophia S.A de C.V.

Completed

Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution (PRO-037)

Dry Eye

Mexico
Allergan

Completed

A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye

Dry Eye Syndromes | Keratoconjunctivitis Sicca

France, United Kingdom
The Hospital for Sick Children

Completed

0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children

Hyponatremia

Canada
Aston University
TearLab Corporation

Completed

Tear Osmolarity Clinical Utility in Dry Eye Disease

Dry Eye

United Kingdom
Atox Bio Ltd

Terminated

Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury

Acute Kidney Injury | Peritonitis | Necrotizing Soft Tissue Infection

United States, France
Allergan

Completed

Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye

Dry Eye Syndromes | Keratoconjunctivitis Sicca

France
Faes Farma, S.A.
ORA, Inc.

Completed

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

Allergic Conjunctivitis

United States
Fang Duan

Unknown

0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation

Corneal Epithelium Exfoliation

China
Kowa Company, Ltd.

Completed

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Dyslipidemias

Japan
Hasanuddin University

Completed

Prolotherapy Intervention Effect in Patient With Knee Osteoarthritis

Knee Osteoarthritis

Indonesia
University of Texas Southwestern Medical Center
US Department of Veterans Affairs

Completed

Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer

Rectal Cancer

United States
NovaBay Pharmaceuticals, Inc.

Completed

Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation

Urinary Catheter Blockage and Encrustation

United States
Chong Kun Dang Pharmaceutical

Unknown

Study to Evaluate the Efficacy and Safety of CKD-350

Dry Eye Syndrome

Korea, Republic of
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

A Randomized Study of Smile Exercise for Dry Eye

Eye Diseases | Dry Eye | Keratoconjunctivitis Sicca | Conjunctival Diseases | Corneal Diseases

China
Laboratorios Sophia S.A de C.V.

Completed

Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects (PRO-087/I)

Dry Eye Syndromes | Lubricant Allergy | Tear Disorder

Mexico
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV) (087LATAMFIV)

Dry Eye Syndrome

Mexico
Lithuanian University of Health Sciences
Santen Oy

Recruiting

The Pattern of Dry Eye Disease After Cataract Surgery

Cataract | Ocular Surface Disease | Dry Eye Disease

Lithuania
Kwang Dong Pharmaceutical co., ltd.

Completed

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

Overactive Bladder

Korea, Republic of
Affiliated Hospital of Jiangsu University

Unknown

Intra-articular Injection of MSCs in Treatment of Knee OA

Osteoarthritis | Stem Cells | MSC
Solvay Pharmaceuticals

Completed

Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

Postmenopause

Croatia, Romania, Poland, Ukraine
Actavis Inc.

Completed

A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee

Osteoarthritis

United States
Decibel Therapeutics

Completed

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Ototoxicity

United States, Australia

3

Subscribe